Surging Prevalence of Infectious Diseases Supporting Saudi Arabia Microbiology Cell Culture Market

Growing incidents of infectious diseases, technological advancements, regulatory approvals, and increasing healthcare expenditures are some of the factors driving the growth of the Saudi Arabian microbiology cell culture market. In 2017, the market generated a revenue of $29.8 million, and it is predicted to witness a 4.5% CAGR during the forecast period (2018–2023). Microbial cell culture is the process of multiplying or growing microorganisms in a pre-decided culture medium with the use of a combination of products.

Based on the type of cell culture storage equipment, the Saudi Arabian microbiology cell culture market is bifurcated into refrigerators and freezers, and cryostorage systems. Of these, during the forecast period, the former are expected to lead the market in terms of revenue, but the cryostorage systems bifurcation is predicted to witness the higher CAGR of more than 5.0%. These systems are deployed for preserving cells stocks when the cell lines go through continuous culture, to curb the loss of cell viability.

To Learn More About this Report: http://bit.ly/2XJvaiK
The Saudi microbiology cell culture market is observing a trend of automation in microbiology that helps in meeting the increasing necessity for higher test volumes and faster turnaround in laboratories. The deployment of the computer technology and use of laboratory interface systems reduce the sample volumes and deliver accurate results. In addition, the availability of matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry equipment has improved the routine identification workflow of pathogenic viruses, fungi, and bacteria.

Additionally, in Saudi Arabia, the growing incidents of infectious diseases, such as malaria, tuberculosis (TB), and invasive streptococcus pneumoniae infection, are accelerating the need for advanced healthcare infrastructure and resources. As per the Global Tuberculosis Report released by the World Health Organization, in 2012, Saudi Arabia, reporting a yearly TB incidence of 18 cases per 100,000 people, remains a country with moderate TB burden. Thus, the increasing prevalence of infectious diseases is boosting the adoption of microbial identification methods for diagnosis and treatment, thereby leading to the progress of the microbiology cell culture market in Saudi Arabia.

Hence, the advancements in cell culture technology and an increasing number of regulatory approvals are expected to help the market advance during the forecast period.

Share:

No comments:

Post a Comment

Popular Posts

Blog Archive